CD8A and neoplasm: To confirm the tumorigenic role of circRHBDD1, its inhibition has been studied in a xenograft model: mice with silenced circRHBDD1 cells presented a better response to anti-PD-1 therapy and an increased infiltration of CD8 cells in tumor tissue [141].